Federal / Public Agency · Consolidated Sponsor Hub
National Heart, Lung, and Blood Institute (NHLBI): Clinical Trials & FDA Approval Profile
National Heart, Lung, and Blood Institute (NHLBI) (Global / Institutional) sponsors 30 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 15 active protocols (8 recruiting now), 9 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.